Cycline efficacy on the propagation of human prions in primary cultured neurons is strain-specific

Journal of Infectious Diseases

Volumn 209, Issue 7, 2014, Pages 1144-1148

  Hannaoui, Samia ^a,b,c,d   Gougerot, Alexianne ^a,b,c,d   Privat, Nicolas ^a,b,c,d   Levavasseur, Etienne ^a,b,c,d   Bizat, Nicolas ^a,b,c,d,e   Hauw, Jean Jacques ^d   Brandel, Jean Philippe ^a,b,c,d   Haïk, Stéphane ^a,b,c,d  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Creutzfeldt Jakob disease; isolates; prion; strain; treatment

Indexed keywords

DOXYCYCLINE; MINOCYCLINE; PRION PROTEIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE AGENT; GRANULE CELL; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

CREUTZFELDT-JAKOB DISEASE; ISOLATES; PRION; STRAIN; TREATMENT;

CELLS, CULTURED; DOXYCYCLINE; HUMANS; NEURONS; PRIONS;

EID: 84898992094     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit623     Document Type: Article

References (15)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44. (Pubitemid 12089840
2. Haik S, Brandel JP. Biochemical and strain properties of CJD prions: Complexity versus simplicity. J Neurochem 2011; 119:251-61
3. Trevitt CR, Collinge J. A systematic review of prion therapeutics in experimental models. Brain 2006; 129:2241-65. (Pubitemid 44522112
4. Forloni G, Iussich S, Awan T, et al. Tetracyclines affect prion infectivity. Proc Natl Acad Sci USA 2002; 99:10849-54
5. Tagliavini F, Forloni G, Colombo L, et al. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. J Mol Biol 2000; 300:1309-22
6. De Luigi A, Colombo L, Diomede L, et al. The efficacy of tetracyclines in peripheral and intracerebral prion infection. PLOS One 2008; 3: E1888
7. Beringue V, Le Dur A, Tixador P, et al. Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLOS One 2008; 3:e1419
8. Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83:79-90
9. Cronier S, Laude H, Peyrin JM. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc Natl Acad Sci USA 2004; 101:12271-6. (Pubitemid 39145433
10. Hannaoui S, Maatouk L, Privat N, Levavasseur E, Faucheux BA, Haik S. Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type. J Virol 2013; 87:2535-48
11. Brandel JP, Heath CA, Head MW, et al. Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain. Ann Neurol 2009; 65:249-56
12. Gies E, Wilde I, Winget JM, et al. Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition. PLOS One 2010; 5:e14410
13. Bishop MT, Will RG, Manson JC. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 2010; 107:12005-10
14. Diomede L, Cassata G, Fiordaliso F, et al. Tetracycline and its analogues protect Caenorhabditis elegans from beta amyloid-induced toxicity by targeting oligomers. Neurobiol Dis 2010; 40:424-31
15. Margalith I, Suter C, Ballmer B, et al. Polythiophenes inhibit prion propagation by stabilizing prion protein (PrP) aggregates. J Biol Chem 2012; 287:18872-87